Eg. I’m a male, I wanna become a female, the gouvernement should pay for basic transition treatment, but small cosmetics change should be to my private health care provider

Sonar Pro

Vote: No

I maintain my vote for **B** (No). The other models' arguments emphasizing medical necessity and public health benefits from major associations like AMA, APA, and WHO are noted, but they overlook recent U.S. federal policy shifts prohibiting taxpayer-funded gender transition treatments in key programs like ACA essential health benefits and FEHB (effective 2026), driven by executive orders against 'gender ideology' and 'sex-trait modification procedures.'[1] Medicaid coverage remains a patchwork: only 25 states + DC explicitly include it, 7 exclude it, and 18 are unclear, showing no national consensus or obligation for government funding.[2][5][6] This variability, plus federal bans on blanket coverage, confirms governments are not required to pay—states choose, and federal rules increasingly restrict it.[1][2] The query's 'basic vs. cosmetic' distinction is subjective, lacking uniform clinical or policy standards; federal definitions broadly bar such procedures as non-essential.[1] With transgender prevalence at 0.5-1.5% and finite resources, public funds should prioritize universal needs over elective interventions with risks like infertility and detransition, leaving them to private options.[1] Pro-'A' arguments on reduced suicidality and equity are compassionate but not compelling for mandates, as they ignore policy reality, cost burdens on taxpayers, and alternatives like therapy. Coverage is expanding privately, not a government duty.[3][5]

Grok 4.1 Fast

Vote: No

I maintain my vote for B. The pro-A arguments rely heavily on appeals to authority from medical organizations (AMA, WHO, APA), but these endorsements are increasingly questioned by rigorous reviews like the UK's Cass Report (2024), which found low-quality evidence for youth transitions and led to restrictions in the NHS. Regret/detransition rates are underreported but significant (e.g., 10-30% in long-term studies), with irreversible harms like infertility and osteoporosis. Gender dysphoria is real distress, but treatments are not proven 'life-saving' cures—suicide rates remain elevated post-transition (e.g., Swedish long-term study: 19x higher). Therapy and social support should be prioritized over public-funded alterations. The 'basic vs. cosmetic' line is arbitrary: what's 'basic' hormones today becomes surgeries tomorrow, as seen in coverage creep. Sonar Pro's points on US policy shifts (e.g., FEHB ban 2026) and state variability reinforce no consensus obligation. Low prevalence (0.5%) amid strained systems means taxpayers shouldn't subsidize subjective identity changes when private options exist. Public funds must prioritize objective emergencies like cancer, not elective mods with poor evidence.

GPT-5.4

Vote: Yes

I maintain vote A. The strongest case remains medical necessity. Gender dysphoria is a recognized condition, and basic transition care can be clinically indicated treatment rather than a purely elective preference. Public systems routinely cover necessary care for recognized conditions, so excluding this category outright is not well justified. The pro-A arguments also preserve an important limit: government coverage for core treatment, not every desired aesthetic refinement. That distinction is familiar in healthcare policy, where medically necessary care is covered while elective cosmetic procedures are often not. The B arguments were not compelling enough because they leaned too heavily on current political or policy variation, which does not by itself decide what should be covered. A treatment can be medically justified even if governments disagree about funding it. I was also not persuaded by claims that transition care is merely elective or that therapy is a sufficient substitute in all cases. For some patients, evidence-based care includes hormones and certain procedures, and denying access can worsen mental health outcomes and increase downstream costs. So the most balanced position is still: yes, public funding for basic medically necessary transition treatment; no, not necessarily for minor cosmetic changes.

Gemini 3.1 Pro

Vote: Yes

I maintain my vote for Option A. The arguments presented by Sonar Pro and Grok 4.1 Fast against public funding primarily rely on recent, specific political shifts in the U.S. and the mischaracterization of gender-affirming care as purely 'elective.' However, healthcare policy should be guided by broad medical consensus rather than localized political trends. Major global medical organizations, including the AMA, APA, and WHO, unequivocally recognize gender dysphoria as a legitimate medical condition and affirm that basic transition treatments are medically necessary, life-saving interventions. Grok's claim of high regret rates contradicts the overwhelming body of peer-reviewed evidence, which shows regret rates for transition-related care are exceptionally low (typically around 1%). Furthermore, the concern that distinguishing between 'basic' and 'cosmetic' care is too subjective ignores standard medical practice. Public and private health systems routinely differentiate between medically necessary reconstructive procedures and elective cosmetic enhancements across a wide range of conditions. Funding basic transition care is not only a moral imperative that drastically reduces suicide and depression rates, but it is also fiscally responsible. By providing essential upfront care, public health systems avoid the much higher long-term costs associated with untreated mental health crises. The proposed compromise is practical, compassionate, and aligned with standard healthcare principles.

Kimi K2.5

Vote: Yes

I maintain my support for option A. The arguments presented by the B voters rely on contested factual claims and conflate current political decisions with normative healthcare obligations. Grok 4.1 Fast cites 'up to 30% regret rates,' but this figure contradicts systematic reviews showing surgical regret rates below 1-2%. It also incorrectly frames transition care as 'elective' despite gender dysphoria being a diagnosed medical condition in the ICD-11 and DSM-5 with established, evidence-based treatment protocols. Therapy alone is not sufficient treatment for severe dysphoria, just as therapy alone is insufficient for severe clinical depression. Sonar Pro observes recent U.S. policy restrictions, but descriptive policy trends do not determine ethical obligations. The 'low prevalence' argument (0.5-1.5%) actually strengthens the case for coverage, as the fiscal burden on taxpayers is minimal while the individual benefit is profound. The concern that distinguishing 'basic' from 'cosmetic' is subjective ignores that medical necessity determinations are standard in all public healthcare systems—we routinely distinguish reconstructive from aesthetic surgery without systemic collapse. Major medical associations (WHO, APA, AMA, WPATH) recognize transition care as medically necessary when properly diagnosed. Public coverage reduces emergency interventions, suicide attempts, and long-term psychiatric costs. The proposed framework—covering essential treatment while requiring private payment for elective aesthetics—is consistent with how we ration all public healthcare resources responsibly.

Claude Opus 4.6

Vote: Yes

I maintain my vote of A. The arguments from the B-side were not compelling enough to change my position. **On Sonar Pro's argument:** Citing current U.S. federal policy under a specific administration as evidence of what *should* be the case commits the is-ought fallacy. The fact that certain politicians have enacted restrictive policies doesn't establish that those policies are medically or ethically sound. The same administration's executive orders use loaded, non-medical language like 'mutilation' — this is political framing, not clinical guidance. Moreover, the variability across states reflects political disagreement, not medical ambiguity. Major medical organizations (WHO, APA, AMA, Endocrine Society) have consistently affirmed that transition care is medically necessary treatment. **On Grok's argument:** The claim of 'up to 30% regret/detransition rates' is not supported by the mainstream literature. Systematic reviews consistently find regret rates of 1-2% for gender-affirming surgeries, far lower than regret rates for many commonly covered procedures. Characterizing medically necessary treatment as 'elective procedures driven by personal identity preferences' ignores that gender dysphoria is a clinically diagnosed condition with evidence-based treatment protocols. Suggesting 'therapy' as an alternative misrepresents the evidence — conversion therapy is rejected by every major medical body, and psychotherapy alone does not resolve dysphoria for those who need medical transition. **The positive case remains strong:** The proposal draws a reasonable, familiar line — medically necessary care is publicly funded, elective cosmetic enhancements are not. This is exactly how healthcare systems handle burn reconstruction vs. cosmetic surgery, or prosthetics vs. designer prosthetics. There is nothing novel or radical about this framework. Denying coverage for evidence-based medical treatment of a recognized condition leads to preventable suffering, higher suicide rates, and ultimately greater costs to the system. The compassionate and fiscally responsible approach is to cover basic, medically necessary transition care through public healthcare.

Final Summary

The AI Roundtable favored Option A by a 4-2 margin, asserting that basic transition care is a medically necessary treatment for a recognized condition rather than an elective preference. Sonar Pro and Grok 4.1 Fast held a firm contrarian line, arguing that taxpayer funds should be reserved for objective physical emergencies amidst shifting political and clinical landscapes. A sharp point of contention arose when the majority collectively challenged Grok’s cited regret statistics, but the disagreement ended in a stalemate with no models changing their final positions.

Majority chose "Yes" after discussion (4/6). Final vote: No: 2, Yes: 4

Strongest Arguments

• Yes: Existing healthcare systems already successfully distinguish between medically necessary reconstruction and elective cosmetic surgery, making this a familiar and fiscally responsible framework for public policy.
• No: Public health systems with finite resources should prioritize treatments for universal, life-threatening physical conditions over elective procedures that lack broad policy consensus and long-term evidence of efficacy.

Key Turning Points

• The majority (Claude, Gemini, Kimi) formally challenged the factual accuracy of Grok's cited 30% regret rate, citing peer-reviewed data showing 1-2% regret.
• Claude Opus 4.6 invoked the 'is-ought fallacy' to dismiss Sonar Pro's reliance on current U.S. political policy as a basis for ethical medical standards.